Cancer Genetics – News and Features

In this article, the latest challenges in interpreting complex genomic cancer profiles and the improvements needed to overcome them are discussed.

Cervical cancer frequently resists treatment. The researchers’ machine learning algorithm could help scientists better understand why this and other forms of cancer resist chemotherapy.

A study carried out at CNIO in collaboration with Korean researchers proposes a new type of cancer predisposition genes and suggests further mechanisms of action for those already known.

Potential "cells of origin" that grow into breast cancer in people with a faulty BRCA2 gene have been identified, and researchers have shown they have the potential to be targeted with drugs.

Dr. Duane Mellor, an award-winning registered dietitian, explains the differences between nitrites and nitrates and why some health experts are concerned about them.

Northwestern Medicine investigators have identified a previously unknown regulator of tumor immune evasion, which may help improve the efficacy of current and future anti-tumor immunotherapies.

In the largest study of its kind, scientists report how combining health data with whole genome sequence (WGS) data in patients with cancer can help doctors provide more tailored care for their patients.

Researchers discover unexpected patterns in mutation risks across individuals, uncovering 13 distinct genomic patterns. The study provides crucial insights into cancer evolution and identifies the genes most affected by changes in mutation risk.

Garvan researchers have revealed a reason why endocrine resistance develops in breast cancers and how to potentially treat it in patients.

Precision medicine and immunotherapy have the potential to revolutionize cancer treatment, but challenges must be addressed to ensure their smooth integration into clinical practice.